|Study Description:||The goal of this clinical research study is to learn if ipilimumab and |
nivolumab can help to control uveal melanoma.
Ipilimumab is designed to increase the immune system's ability to fight cancer.
Nivolumab is an antibody (a protein that attacks foreign cells) that is
designed to allow the body’s immune system to work against tumor cells.